Fat Loss

Fat Loss & Body Recomposition Stack

Most fat loss approaches sacrifice muscle alongside fat — this stack prevents that trade-off by targeting three points on the GH-fat axis simultaneously. AOD-9604 directly stimulates fat breakdown without affecting IGF-1 or blood glucose, Tesamorelin produces sustained GH release with the strongest clinical evidence for visceral fat reduction, and Ipamorelin amplifies total GH output through a clean, complementary pathway. Used alongside a moderate caloric deficit and adequate protein, this stack meaningfully accelerates recomposition while actively protecting lean mass.

Intermediate 12 week cycle 3 peptides Save
For educational and research purposes only. Not medical advice. This protocol describes research use, not human administration. Always consult a qualified professional.

Protocol & Dosing

Weeks 1–4 — Baseline Phase:

  • AOD-9604: 300 mcg subcutaneously each morning (fasted, 30 min before eating)
  • Ipamorelin: 200 mcg subcutaneously before bed (fasted)
Weeks 5–12 — Full Stack:
  • AOD-9604: 300 mcg subcutaneously each morning (fasted)
  • Tesamorelin: 1 mg subcutaneously each morning (fasted, same time as AOD)
  • Ipamorelin: 200–300 mcg subcutaneously before bed (fasted)
Cycle: 12 weeks on / 4 weeks off

Notes: Fasted morning dosing of AOD and Tesamorelin is essential — insulin inhibits GH release. Maintain a protein intake of at least 1.6 g/kg bodyweight throughout the cycle. Resistance training 3–4x per week significantly enhances recomposition results. Do not use AOD-9604 as a substitute for dietary discipline.

Calculate Doses for This Stack

Use the Peptide Oracle calculator to get exact BAC water ratios and draw amounts for every peptide in this protocol.

Open Dosage Calculator